Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Messenger RNA Developer ETF Launches

Investor screen

A new exchange traded fund or ETF is underway for individuals to invest in companies developing vaccines or therapies with messenger RNA. . . . → Read More: Messenger RNA Developer ETF Launches

Mid-Week Break

Camera and laptop

Our regular posts will resume tomorrow. . . . → Read More: Mid-Week Break

NIH Opens $1M Maternal Health Diagnostics Challenge

Pregnant woman

National Institutes of Health began a competition for low-cost diagnostic technologies to improve maternal health, particularly in low-resource regions. . . . → Read More: NIH Opens $1M Maternal Health Diagnostics Challenge

Trial Shows Nasal Spray Relieves Migraine Pain

Nasal spray

Clinical trial results show a nasal spray treatment for acute migraine helps more users achieve relief from pain within two hours, and faster in some cases. . . . → Read More: Trial Shows Nasal Spray Relieves Migraine Pain

Infographic – Huge Quantum Computing Growth Forecast

Chart: quantum computing

Quantum computing is expected to make major gains in this decade, with the global market size for this technology accelerating in that time. . . . → Read More: Infographic – Huge Quantum Computing Growth Forecast

AI-Aided Fall Prevention System Gains $30M in New Funds

Old person with walker

A developer of a system using artificial intelligence to process video for preventing falls by older people is raising $30 million in its second venture round. . . . → Read More: AI-Aided Fall Prevention System Gains $30M in New Funds

Oxford, GSK Partner on New Tech for Neuro Diseases

Brain circuits illustration

GlaxoSmithKline is funding a joint research center at University of Oxford to advance precision medical technologies, beginning with neurological disorders. . . . → Read More: Oxford, GSK Partner on New Tech for Neuro Diseases

$180M Venture Fund Backing Age-Related Disease Start-Ups

Hands of older person

A new venture capital fund aims to finance research entrepreneurs addressing root causes of age-related diseases with therapies and early diagnostics. . . . → Read More: $180M Venture Fund Backing Age-Related Disease Start-Ups